To examine the rate of Gleason sum upgrading (GSU) from a sum of 6 to a Gleason sum of 7 in patients undergoing radical prostatectomy (RP), who fulfilled the recommendations for low dose rate brachytherapy (Gleason sum 6, prostate-specific antigen 10 ng/mL, clinical stage T2a and prostate volume 50 mL), and to test the performance of an existing nomogram for prediction of GSU in this specific cohort of patients.
To examine the rate of Gleason sum upgrading (GSU) from a sum of 6 to a Gleason sum of 7 in patients undergoing radical prostatectomy (RP), who fulfilled the recommendations for low dose rate brachytherapy (Gleason sum 6, prostate-specific antigen 10 ng/mL, clinical stage T2a and prostate volume 50 mL), and to test the performance of an existing nomogram for prediction of GSU in this specific cohort of patients.